Are there generic versions of Copanlisib?
Copanlisib/Copanlisib (Copanlisib) is an innovative anti-cancer drug that belongs to the class of phosphatidylinositol3kinase (PI3K) inhibitors. Its main use is to treat certain types of leukemia and lymphoma, especially adult follicular lymphoma (Follicular Lymphoma).
Copanliside/Copanisib There are currently no generic drugs on the market. Copanliside/Kupanisi has just been launched in China and has not yet been included in medical insurance. The specific price may not be determined yet. Please consult your local pharmacy for details. There is only the American version of the original drug available abroad, and the price is as high as more than 70,000 yuan.

Copanliside/Copanisib has a very precise mechanism of action. It interferes with the growth, division and survival of cancer cells by inhibiting the activity of the PI3K pathway. PI3K is a protein kinase that is normally involved in cell signaling. However, in some cancers, the PI3K pathway is abnormally active, promoting uncontrolled proliferation of cancer cells. Copanliside/Kupanisi’s intervention works in the following ways:
Cell proliferation control: Copanliside/Kupanisi Reduces the progression of cancer by slowing down the proliferation rate of cancer cells, making it difficult for them to divide and proliferate.
Cell survival inhibition: This drug inhibits the activity of thePI3K pathway, prompting cancer cells to undergo programmed cell death, thus reducing their survival rate.
Angiogenesis inhibition: Copanliside/CopanisibIt also inhibits the formation of tumor blood vessels and weakens the blood supply to cancer cells, thus limiting the growth of cancer tumors.
Copanliside/CopanisibUsually administered by injection, a personalized treatment plan is required based on the patient's specific conditions. However, drug use may be associated with some adverse effects, including low white blood cell counts, high blood sugar, high blood pressure, diarrhea, and fatigue. Therefore, when using copanlised/cupanisi, doctors will closely monitor the patient's condition and side effects to ensure the effectiveness and safety of the treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)